BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3652053)

  • 1. Estrogen receptor-binding affinity and cytotoxic activity of three new estrogen-nitrosourea conjugates in human breast cancer cell lines in vitro.
    Lam HY; Ng PK; Goldenberg GJ; Wong CM
    Cancer Treat Rep; 1987 Oct; 71(10):901-6. PubMed ID: 3652053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E; Day BW
    Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines.
    Otto AM; Faderl M; Schönenberger H
    Cancer Res; 1991 Jun; 51(12):3217-23. PubMed ID: 2039997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
    Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer.
    Akama T; Shida Y; Sugaya T; Ishida H; Gomi K; Kasai M
    J Med Chem; 1996 Aug; 39(18):3461-9. PubMed ID: 8784443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of histochemical and biochemical assays for estrogen receptor in human breast cancer cell lines.
    Parl FF; Wetherall NT; Halter S; Schuffman S; Mitchell WM
    Cancer Res; 1984 Jan; 44(1):415-21. PubMed ID: 6690057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ; Froese EK
    Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer.
    Leclercq G; Devleeschouwer N; Heuson JC
    J Steroid Biochem; 1983 Jul; 19(1A):75-85. PubMed ID: 6887875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR; Murphy LC; Hall RE; Sutherland RL
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates.
    Devraj R; Barrett JF; Fernandez JA; Katzenellenbogen JA; Cushman M
    J Med Chem; 1996 Aug; 39(17):3367-74. PubMed ID: 8765520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects in the development of cytotoxic-linked estrogens for the control of breast neoplasia.
    Leclercq G
    Arch Geschwulstforsch; 1981; 51(7):643-9. PubMed ID: 7337547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.
    Swamy N; Purohit A; Fernandez-Gacio A; Jones GB; Ray R
    J Cell Biochem; 2006 Oct; 99(3):966-77. PubMed ID: 16741968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
    Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
    Pihie AH; Stanslas J; Din LB
    Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells.
    Mitropoulou TN; Tzanakakis GN; Nikitovic D; Tsatsakis A; Karamanos NK
    Anticancer Res; 2002; 22(5):2841-6. PubMed ID: 12530007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.